• DiaMedica pulls off IPO to fund midphase stroke trial fiercebiotech
    December 28, 2018
    DiaMedica Therapeutics has wrapped up its IPO. The offering gives DiaMedica the cash to take its lead candidate through phase 2 trials in acute ischemic stroke (AIS) and chronic kidney disease (CKD).....
PharmaSources Customer Service